Date de publication: 16 mars 2021
Promoteur – Intermédiaire Financier
RWANDA BIOMEDICAL CENTRELieu
Description
The project will finance the reconstruction of the Rwanda Biomedical Centre (the Medical Technology Unit, the National Centre for Blood Transfusion, the National Reference Laboratory and the Research, Innovation & Data Science Division), and potentially other health interventions from the Rwanda COVID-19 National Response Plan.
Objectifs
The operation's objective is to help the Government of Rwanda meet needs in the health sector directly related to the COVID-19 pandemic in line with the Government's "COVID-19 National Preparedness and Response Plan."
Secteur(s)
- Santé - Santé humaine et action sociale
Under Global Europe NDICI guarantee
Under EFSD+ Guarantee
Montant BEI envisagé (montant approximatif)
EUR 26 million
Coût total (montant approximatif)
EUR 27 million
Aspects environnementaux
The Bank will require the Promoter to ensure that the implementation of the project will be done in accordance with the Bank's Environmental and Social principles and standards. The Bank will require the project's compliance with the relevant environmental legislation and alignment of the Bank's Environmental and Social principles and standards. The Bank's services will assess the full environmental details during the project due diligence.
Passation des marchés
The Bank will require the Promoter to ensure that implementation of the project will be done in accordance with the Bank's Guide to Procurement.
Statut
Signé - 29/09/2021